About
Jacob Corn is a genome biologist and professor at ETH Zurich focused on CRISPR and therapeutic genome editing. He has held leadership roles in the Innovative Genomics Institute's biomedical applications work and is publicly identified as a co-founder and board member of Spotlight Therapeutics. He also serves in advisory and collaborative scientific roles across translational gene-editing programs.
Areas of interest
biotechgene editingCRISPRgenome biologycell and gene therapysickle cell diseaserare genetic diseasestranslational medicine